BCL2 and neoplasm: By targeting multiple genes, such as Bcl-2, cyclin D1 and silent information regulator 1, miRNA-34a is able to suppress tumor angiogenesis, induce cancer cell apoptosis, block proliferation, revert the EMT, and thereby inhibit tumor growth12, 13, 14.